Effectiveness of therapeutic heparin versus prophylactic heparin on death, mechanical ventilation, or intensive care unit admission in moderately ill patients with covid-19 admitted to hospital: RAPID randomised clinical trial

Sholzberg, Michelle; H. Tang, Grace; Rahhal, Hassan; AlHamzah, Musaad; Baumann Kreuziger, Lisa; Ní Áinle, Fionnuala; Alomran, Faris; Alayed, Khalid; AlSheef, Mohammed; AlSumait, Fahad; Eduardo Pompílio, Carlos; Sperlich, Catherine; Tangri, Sabrena; Tang, Terence; Jaksa, Peter; Suryanarayan, Deepa; Almarshoodi, Mozah; A. Castellucci, Lana; D. James, Paula; Lillicrap, David; Carrier, Marc; Beckett, Andrew; Colovos, Christos; Jayakar, Jai; Arsenault, Marie-Pier; Wu, Cynthia; Doyon, Karine; Andreou, Εleni; Dounaevskaia, Vera; Tseng, Eric; Lim, Gloria; Fralick, Michael; Middeldorp, Saskia; Lee, Agnes; Zuo, Fei; R. da Costa, Bruno; E. Thorpe, Kevin; Márcia Negri, Elnara; Cushman, Mary; Jüni, Peter

doi:10.1136/bmj.n2400

Public

Effectiveness of therapeutic heparin versus prophylactic heparin on death, mechanical ventilation, or intensive care unit admission in moderately ill patients with covid-19 admitted to hospital: RAPID randomised clinical trial

Published in BMJ • Oct 14, 2021

Authors:

Michelle Sholzberg

Grace H. Tang

Hassan Rahhal

Abstract

OBJECTIVE: To evaluate the effects of therapeutic heparin compared with prophylactic heparin among moderately ill patients with covid-19 admitted to hospital wards. DESIGN: Randomised controlled, adaptive, open label clinical trial. SETTING: 28 hospitals in Brazil, Canada, Ireland, Saudi Arabia, Uni...

Subject

Medicine

Heparin

Mechanical ventilation

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!